287 related articles for article (PubMed ID: 16971313)
1. Hidradenitis suppurativa treated with dapsone: A case series of five patients.
Kaur MR; Lewis HM
J Dermatolog Treat; 2006; 17(4):211-3. PubMed ID: 16971313
[TBL] [Abstract][Full Text] [Related]
2. Infliximab for the treatment of hidradenitis suppurativa.
Fernández-Vozmediano JM; Armario-Hita JC
Dermatology; 2007; 215(1):41-4. PubMed ID: 17587838
[TBL] [Abstract][Full Text] [Related]
3. Dapsone therapy for hidradenitis suppurativa: a series of 24 patients.
Yazdanyar S; Boer J; Ingvarsson G; Szepietowski JC; Jemec GB
Dermatology; 2011; 222(4):342-6. PubMed ID: 21757878
[TBL] [Abstract][Full Text] [Related]
4. [Radiotherapy of hidradenitis suppurativa--still valid today?].
Fröhlich D; Baaske D; Glatzel M
Strahlenther Onkol; 2000 Jun; 176(6):286-9. PubMed ID: 10897256
[TBL] [Abstract][Full Text] [Related]
5. [Hidradenitis suppurativa. Response to treatment with infliximab].
Pedraz J; Daudén E; Pérez-Gala S; Goiriz-Valdés R; Fernández-Peñas P; García-Diez A
Actas Dermosifiliogr; 2007 Jun; 98(5):325-31. PubMed ID: 17555675
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa.
Mekkes JR; Bos JD
Br J Dermatol; 2008 Feb; 158(2):370-4. PubMed ID: 18047504
[TBL] [Abstract][Full Text] [Related]
7. Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients' outcome assessment.
Soria A; Canoui-Poitrine F; Wolkenstein P; Poli F; Gabison G; Pouget F; Viallette C; Revuz J
Dermatology; 2009; 218(2):134-5. PubMed ID: 19060466
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients.
Gener G; Canoui-Poitrine F; Revuz JE; Faye O; Poli F; Gabison G; Pouget F; Viallette C; Wolkenstein P; Bastuji-Garin S
Dermatology; 2009; 219(2):148-54. PubMed ID: 19590173
[TBL] [Abstract][Full Text] [Related]
9. Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study.
Brocard A; Knol AC; Khammari A; Dréno B
Dermatology; 2007; 214(4):325-7. PubMed ID: 17460404
[TBL] [Abstract][Full Text] [Related]
10. An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa.
Giamarellos-Bourboulis EJ; Pelekanou E; Antonopoulou A; Petropoulou H; Baziaka F; Karagianni V; Stavrianeas N; Giamarellou H
Br J Dermatol; 2008 Mar; 158(3):567-72. PubMed ID: 18076705
[TBL] [Abstract][Full Text] [Related]
11. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients.
Fardet L; Dupuy A; Kerob D; Levy A; Allez M; Begon E; Bachelez H; Morel P; Lebbé C
J Am Acad Dermatol; 2007 Apr; 56(4):624-8. PubMed ID: 17240478
[TBL] [Abstract][Full Text] [Related]
12. The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa.
van der Zee HH; Boer J; Prens EP; Jemec GB
Dermatology; 2009; 219(2):143-7. PubMed ID: 19590174
[TBL] [Abstract][Full Text] [Related]
13. [Surgical treatment of hidradenitis suppurativa: a retrospective study of 93 cases].
Bordier-Lamy F; Palot JP; Vitry F; Bernard P; Grange F
Ann Dermatol Venereol; 2008 May; 135(5):373-9. PubMed ID: 18457723
[TBL] [Abstract][Full Text] [Related]
14. Hidradenitis suppurativa treated with finasteride.
Joseph MA; Jayaseelan E; Ganapathi B; Stephen J
J Dermatolog Treat; 2005 Apr; 16(2):75-8. PubMed ID: 16019620
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa.
Join-Lambert O; Coignard H; Jais JP; Guet-Revillet H; Poirée S; Fraitag S; Jullien V; Ribadeau-Dumas F; Thèze J; Le Guern AS; Behillil S; Leflèche A; Berche P; Consigny PH; Lortholary O; Nassif X; Nassif A
Dermatology; 2011 Feb; 222(1):49-58. PubMed ID: 21109728
[TBL] [Abstract][Full Text] [Related]
16. Hidradenitis suppurativa responding to treatment with infliximab.
Lasocki A; Sinclair R; Foley P; Saunders H
Australas J Dermatol; 2010 Aug; 51(3):186-90. PubMed ID: 20695857
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic and prophylactic role of oral zinc sulfate in management of recurrent aphthous stomatitis (ras) in comparison with dapsone.
Sharquie KE; Najim RA; Al-Hayani RK; Al-Nuaimy AA; Maroof DM
Saudi Med J; 2008 May; 29(5):734-8. PubMed ID: 18454224
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of infliximab for hidradenitis suppurativa: assessment of clinical and biological inflammatory markers.
Delage M; Samimi M; Atlan M; Machet L; Lorette G; Maruani A
Acta Derm Venereol; 2011 Mar; 91(2):169-71. PubMed ID: 21384087
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura.
Vancine-Califani SM; De Paula EV; Ozelo MC; Orsi FL; Fabri DR; Annichino-Bizzacchi JM
Platelets; 2008 Nov; 19(7):489-95. PubMed ID: 18979360
[TBL] [Abstract][Full Text] [Related]
20. Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases.
Moschella SL
Int J Dermatol; 2007 Dec; 46(12):1287-91. PubMed ID: 18173525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
